Identification of biomarkers for ambulatory and automated seizure detection.

Recruiting

• Conditions: G40; Epilepsy

• Registration Number: DRKS00026984
• Lead Sponsor: Klinik für Neurologie/Sektion Epileptologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-26
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Epileptic seizures, minimum 24-hour stay in Epilepsy Monitoring Unit.

Exclusion Criteria

Children (under 15 years of age), patients with open wounds in the area of attachment (under the chest), patients wearing a pacemaker, implantable cardioverter defibrillator (ICD) or other electronic implant.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determine sensitivity per patient with seizures (focal as well as generalized seizures). The basis for the seizure yes/no assessment is the EEG.

Secondary Outcome Measures

Name	Time	Method
Determine sensitivity per patient with seizures and simultaneously investigate drug administration, patient groups may be grouped (cluster analysis).<br>Determine false detection rate per patient (epileptic seizure detected where none was according to EEG).<br>Continuous comparison of the two approaches in terms of sensitivity and specificity.<br>